|国家科技期刊平台
首页|期刊导航|化工学报|纳米药物载体用于治疗胞内菌感染的研究进展

纳米药物载体用于治疗胞内菌感染的研究进展OA北大核心CSTPCD

Advances in drug nanodelivery systems for the treatment of intracellular bacterial infections

中文摘要英文摘要

胞内菌能够逃避机体免疫并在宿主细胞内正常生长繁殖,比起胞外细菌更难清除,容易造成较为严重的感染.传统的抗生素治疗,药物无法突破宿主细胞膜的屏障,并且容易引起较强的毒副作用和多药耐药性.优良的纳米载体具有良好的生物相容性且易于修饰,有望通过构建纳米药物递送系统增强抗菌药物的细胞膜穿透性和胞内菌靶向性,在治疗胞内菌感染上具有巨大潜力和广阔前景.介绍了目前可用于治疗胞内菌感染的各种纳米颗粒,归纳总结了增强纳米药物递送系统治疗效果的机制和方法,阐述了目前在使用纳米药物递送系统治疗胞内菌感染时仍存在的问题,以期为构建更优良的纳米药物递送系统治疗胞内菌感染提供启发.

Intracellular bacteria can escape the body's immunity and grow and reproduce normally in the host cell,which are more difficult to remove than extracellular bacteria and can easily cause more serious infections.With traditional antibiotic treatment,the drugs cannot break through the host cell membrane barrier and can easily cause strong toxic side effects and multidrug resistance.Excellent nanocarriers have good biocompatibility and are easy to modify,which is expected to enhance membrane penetration and bacterial targeting of antibacterial drugs through the construction of nanodelivery systems,offering great potential and broad prospects in the treatment of intracellular bacterial infections.This paper introduces various nanoparticles that can be used to treat intracellular bacterial infections,summarizes the mechanisms and methods for enhancing the therapeutic effects of drug nanodelivery systems,and elaborates on the problems that still exist when using nano-drug delivery systems to treat intracellular bacterial infections,in order to provide inspiration for the construction of better drug delivery systems to treat intracellular bacterial infections.

巨晓洁;宋婉璐;周宸宇;沈秋彤;廖雨田;龚珏颖;褚良银

四川大学化学工程学院,四川 成都 610065

化学工程

纳米载体胞内菌细菌靶向抗菌策略

nanocarriersintracellular bacteriabacterial targetingantibacterial strategy

《化工学报》 2024 (004)

双层复合结构微针阵列给药系统的制备及其经皮控释传质特性研究

1153-1166 / 14

国家自然科学基金项目(22078202);四川大学-中国核动力研究设计院联合创新基金项目(JG2022300)

10.11949/0438-1157.20231326

评论